Elsevier

Human Pathology

Volume 26, Issue 7, July 1995, Pages 765-770
Human Pathology

Original contribution
Pancreatic disorders in pediatric acquired immune deficiency syndrome

https://doi.org/10.1016/0046-8177(95)90225-2Get rights and content
Under a Creative Commons license
open archive

Abstract

Acute pancreatitis, reported in 17% of pediatric patients with acquired immune deficiency syndrome (AIDS), is said to have a poor prognosis. We describe the pancreatic changes observed at autopsy from 71 children with human immunodeficiency virus (HIV) infection and document their nature, extent, and clinical relevance. The median age at autopsy of the children was 17 months (range, 2 months to 19 years); 38 were boys and 33 were girls. Parental intravenous drug use was the most frequent risk factor for AIDS, followed by blood transfusions. Respiratory failure and sepsis constituted the predominant causes of death. Nonspecific changes, such as edema, inflammation, fibrosis, inspissated material in acini and ducts, and enlarged Langerhans' islet predominated. Acute and chronic pancreatitis were mild except in one instance of a fatal acute probably dideoxyinosine-associated pancreatitis. Pancreatic involvement by opportunistic infections, such as cytomegalovirus (CMV), Mycobacterium avium intracellulare (MAI), and Candida, was focal and rare despite the high prevalence of these infections at autopsy. Focal lymphoplasmacytic infiltration and vascular calcifications were also observed. We conclude that pancreatic changes were frequently noted at autopsy in children with AIDS. They were usually mild, reflected systemic disease states, and were usually not life threatening. The incidence of opportunistic infections of the pancreas was low.

Keywords

pancreas
pediatric AIDS
immune deficiency
pancreatitis
didanosine

Abbreviations

AIDS
acquired immune deficiency syndrome
TMX
trimethoprim-sulfametho-xazole
HIV
human immunodeficiency virus
CMV
cytomegalovirus
MAI
Mycobacterium avium intracellulare
AZT
azidothymidine
ddi
2′3′dideoxyinosine, (didanosine)
PCP
Pneumocystis carinii pneumonia

Cited by (0)

Presented in part at the Annual Meeting of the American College of Gastroenterology, October 2–3, 1993, New York, NY